L2M Validation / QC Automne 2025 / Next-Generation Paper Diagnostics: Point-of-Care Smart Detection of Infection

This project focuses on creating a low-cost, paper-based sensor that can quickly detect and archive Pseudomonas aeruginosa, a harmful bacterium found in both medical and environmental settings. This includes infections in hospitals and contamination in water systems—two areas where fast, accurate detection is essential for protecting public health. The sensor leverages smart electrochemical technology to […]

Read More
L2M-Oculum-Ontario

Oculum is developing a new imaging system to improve how eye surgeons see delicate, transparent tissues during surgery—without the need for chemical dyes, which are often risky and not approved for many procedures. This project will help Oculum move from early research to real-world use by building the business and operational tools needed to bring […]

Read More
L2M – NeurolAssist

We are developing a specialized AI-driven Clinical Decision Support System (CDSS) for neurology that integrates a large language model with domain-specific tools (such as neuroimaging analysis, EEG interpretation, and up-to-date medical knowledge retrieval). The system serves as an intelligent assistant for neurologists, helping analyze patient data (e.g. MRI scans, EEGs, clinical notes, etc.) and providing […]

Read More
L2M – AllerEase: Personalized Allergy-Safe Grocery Tool

AllerEase is a personalized grocery recommendation tool that helps allergy-sensitive users shop safer and easier. It generates user-specific shopping lists based on allergy profiles and live product data. This project aims to refine matching logic and validate usability through real-world testing.

Read More
Protein-based nanoparticles with novel azole derivatives as antifungals

Increasingly, fungi are becoming resistant to the drugs, antifungals, that we use to treat fungal infections, necessitating research into alternative antifungal strategies. One way to increase the amount and delivery of antifungals to invading fungi within the body is using protein-based nanoparticles. The antifungals associate with the nanoparticles that are delivered and taken in by […]

Read More
L2M Launch / Qc Fall 2025 / Flexible Intra-Oral Device for Continuous Salivary Biomarkers Monitoring to Diagnose Sleep Disorders

Sleep disorders like insomnia and circadian rhythm disruptions affect millions, leading to health problems such as fatigue, difficulty to concentrate, depression, various ailments including heart disease and cancer. Diagnosing these issues is challenging because current methods, such as overnight lab tests, are expensive, uncomfortable, and often unable to accurately perform real-time measurements. Wearable devices help, […]

Read More
New Directions Try Program Assistant Instructor

The New Directions Try program works with youth on a wide scale of risk levels to help them achieve their goals. All the youth in the program have something working against them such as mental or physical disabilities, CPS involvement, and even charges against them and our job is to help set them up for […]

Read More
Next-Generation Wound Dressings: MOF-Loaded 3D-Printed Hydrogels for Diabetic Ulcer Treatment

Diabetic foot ulcers are a major complication of diabetes, often leading to serious infections and even limb amputations. These chronic wounds heal poorly due to prolonged inflammation, oxidative stress, and tissue damage. This project aims to develop an advanced wound dressing that combines natural and synthetic materials with innovative nanotechnology to improve healing outcomes. The […]

Read More
L2M: Development of LuzCornea platform for treating corneal disorders

The goal of this project will be to facilitate the commercializations of LuzCornea, a material to help repair corneas for people with poor vision. To do this, a way to make large volumes of LuzCornea material must be developed in order to help as many people as possible with poor vision and to reduce the […]

Read More
L2M Launch / Qc Fall 2025 / Spheralis Biolabs

We are developing a new class of antibiotics to treat udder infections in dairy cows caused by Staphylococcus aureus, a particularly difficult and costly problem for farmers. While udder infections in general cost the Canadian dairy industry over $800?million each year, those caused by S. aureus are especially challenging to treat, often leading to milk […]

Read More